Quest Diagnostics Company Profile (NYSE:DGX)

About Quest Diagnostics

Quest Diagnostics logoQuest Diagnostics Incorporated is a provider of diagnostic information services. The Company operates through two businesses: Diagnostic Information Services and Diagnostic Solutions. The Company's Diagnostic Information Services business develops and delivers diagnostic testing information and services to patients, physicians, health plans, hospitals, accountable care organizations (ACOs), integrated delivery networks (IDNs), other commercial laboratories, employers and others. The Company's Diagnostic Solutions offers a range of solutions for insurers and healthcare providers. The Company provides risk assessment services for the life insurance industry. In addition, the Company offers healthcare organizations and clinicians' health information technology solutions and diagnostic products. ExamOne provides risk assessment services to the life insurance industry in North America. ChartMaxx is the Company's enterprise content management system for hospitals.

Industry, Sector and Symbol:
  • Sector: Medical
  • Industry: Medical Laboratories & Research
  • Sub-Industry: Health Care Services
  • Exchange: NYSE
  • Symbol: DGX
  • CUSIP: 74834L10
Key Metrics:
  • Previous Close: $79.93
  • 50 Day Moving Average: $83.64
  • 200 Day Moving Average: $80.84
  • 52-Week Range: $59.66 - $86.85
  • Trailing P/E Ratio: 16.96
  • Foreward P/E Ratio: 14.69
  • P/E Growth: 1.95
  • Market Cap: $11.08B
  • Outstanding Shares: 139,000,000
  • Beta: 0.7
  • Net Margins: 9.01%
  • Return on Equity: 14.57%
  • Return on Assets: 6.73%
  • Debt-to-Equity Ratio: 0.81%
  • Current Ratio: 1.57%
  • Quick Ratio: 1.29%
Additional Links:
Companies Related to Quest Diagnostics:

Analyst Ratings

Consensus Ratings for Quest Diagnostics (NYSE:DGX) (?)
Ratings Breakdown: 2 Sell Ratings, 10 Hold Ratings, 1 Buy Rating
Consensus Rating:Hold (Score: 1.92)
Consensus Price Target: $81.50 (1.96% upside)

Analysts' Ratings History for Quest Diagnostics (NYSE:DGX)
DateFirmActionRatingPrice TargetDetails
10/20/2016Canaccord GenuitySet Price TargetBuy$90.00View Rating Details
10/21/2016MizuhoBoost Price TargetNeutral$86.00 -> $88.00View Rating Details
9/9/2016Citigroup Inc.Initiated CoverageNeutral$86.00View Rating Details
7/24/2016Evercore ISIReiterated RatingHold$78.50 -> $89.50View Rating Details
7/22/2016Jefferies GroupBoost Price TargetHold$75.00 -> $86.00View Rating Details
6/24/2016Jyske BankDowngradeNeutral -> SellView Rating Details
6/7/2016Morgan StanleyReiterated RatingSellView Rating Details
5/24/2016Credit Suisse Group AGReiterated RatingHoldView Rating Details
5/22/2016KeyCorpReiterated RatingHoldView Rating Details
5/16/2016Robert W. BairdReiterated RatingHoldView Rating Details
4/22/2016Barclays PLCBoost Price TargetEqual Weight$72.00 -> $75.00View Rating Details
4/22/2016Royal Bank Of CanadaBoost Price TargetSector Perform$70.00 -> $76.00View Rating Details
3/23/2016Goldman Sachs Group Inc.Boost Price Target$71.00View Rating Details
1/29/2016William BlairReiterated RatingHoldView Rating Details
10/16/2015Wells Fargo & Co.UpgradeUnderperform -> Market PerformView Rating Details
3/27/2015JMP SecuritiesInitiated CoverageMarket PerformView Rating Details
3/25/2015Deutsche Bank AGDowngradeBuy -> Hold$77.00 -> $80.00View Rating Details
2/23/2015Bank of America Corp.DowngradeNeutral -> Underperform$71.00 -> $68.00View Rating Details
1/29/2015Craig HallumDowngradeBuy -> HoldView Rating Details
1/2/2015Raymond James Financial Inc.UpgradeUnderperform -> Market PerformView Rating Details
(Data available from 10/27/2014 forward)


Earnings History for Quest Diagnostics (NYSE:DGX)
DateQuarterConsensus EstimateActual EPSRevenue EstimateActual RevenueRelease LinkConference CallDetails
10/20/2016Q316$1.35$1.37$1.53 billion$1.89 billionViewListenView Earnings Details
7/21/2016Q216$1.32$1.34$1.91 billion$1.91 billionViewListenView Earnings Details
4/21/2016Q116$1.12$1.12$1.82 billion$1.86 billionViewListenView Earnings Details
1/28/2016Q415$1.19$1.19$1.85 billion$1.85 billionViewListenView Earnings Details
10/22/2015Q315$1.26$1.28$1.89 billion$1.88 billionViewListenView Earnings Details
7/23/2015Q215$1.23$1.25$1.93 billion$1.93 billionViewListenView Earnings Details
4/23/2015Q115$1.04$1.05$1.85 billion$1.84 billionViewListenView Earnings Details
1/29/2015Q414$1.04$1.08$1.85 billion$1.90 billionViewListenView Earnings Details
10/23/2014Q314$1.08$1.10$1.87 billion$1.90 billionViewListenView Earnings Details
7/24/2014Q214$1.06$1.08$1.88 billion$1.90 billionViewN/AView Earnings Details
4/24/2014Q114$0.89$0.84$1.75 billion$1.75 billionViewListenView Earnings Details
1/30/2014Q413$0.93$0.97$1.74 billion$1.76 billionViewListenView Earnings Details
10/17/2013Q313$1.20$1.02$1.84 billion$1.79 billionViewListenView Earnings Details
7/18/2013Q2 2013$1.10$1.06$1.84 billion$1.82 billionViewListenView Earnings Details
4/17/2013Q1 2013$1.03$0.89$1.86 billion$1.80 billionViewListenView Earnings Details
1/23/2013Q4 2012$1.02$1.01$1.83 billion$1.77 billionViewListenView Earnings Details
10/17/2012$1.18$1.18ViewN/AView Earnings Details
7/19/2012$1.17$1.17ViewN/AView Earnings Details
4/18/2012$1.01$1.07ViewN/AView Earnings Details
1/24/2012$1.06$1.23ViewN/AView Earnings Details
10/25/2011$1.11$1.18ViewN/AView Earnings Details
7/20/2011$1.12$1.12ViewN/AView Earnings Details
4/20/2011$1.01$1.00ViewN/AView Earnings Details
1/25/2011$0.91$0.98ViewN/AView Earnings Details
(Data available from 1/1/2011 forward)


Earnings Estimates for Quest Diagnostics (NYSE:DGX)
Current Year EPS Consensus Estimate: $5.10 EPS
Next Year EPS Consensus Estimate: $5.44 EPS
QuarterNumber of EstimatesLow EstimateHigh EstimateAverage Estimate
Q1 20164$1.00$1.15$1.09
Q2 20165$1.31$1.33$1.32
Q3 20165$1.33$1.39$1.36
Q4 20165$1.26$1.30$1.28
Q1 20172$1.21$1.26$1.24
Q2 20172$1.42$1.45$1.44
Q3 20172$1.44$1.44$1.44
Q4 20172$1.38$1.44$1.41
(Data provided by Zacks Investment Research)


Current Dividend Information for Quest Diagnostics (NYSE:DGX)
Annual Dividend:$1.60
Dividend Yield:2.00%
Dividend Growth:29.30% (3 Year Average)
Payout Ratio:34.04% (Based on Trailing 12 Months of Earnings)
31.37% (Based on Current Year Consensus EPS Estimate)
29.41% (Based on Next Year Consensus EPS Estimate)
Track Record:4 Years of Consecutive Dividend Growth

Dividend History for Quest Diagnostics (NYSE:DGX)
AnnouncedPeriodAmountYieldEx-Dividend DateRecord DatePayable Date
(Data available from 1/1/2013 forward)

Insider Trades

Insider Trading History for Quest Diagnostics (NYSE:DGX)
Insider Ownership Percentage: 1.50%
Institutional Ownership Percentage: 91.29%
Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionDetails
8/19/2016Jenne K BritellDirectorSell4,000$84.76$339,040.00View SEC Filing  
8/10/2016Jenne K BritellDirectorSell4,000$85.20$340,800.00View SEC Filing  
8/3/2016Jeffrey M LeidenDirectorSell6,345$85.62$543,258.90View SEC Filing  
7/25/2016John B. ZieglerDirectorSell1,000$84.36$84,360.00View SEC Filing  
5/27/2016Catherine T DohertySVPSell47,334$77.27$3,657,498.18View SEC Filing  
5/12/2016Jenne K BritellDirectorSell8,000$75.68$605,440.00View SEC Filing  
5/9/2016Everett CunninghamSVPSell56,312$76.26$4,294,353.12View SEC Filing  
5/6/2016Everett CunninghamSVPSell50,447$76.00$3,833,972.00View SEC Filing  
4/25/2016Catherine T DohertySVPSell29,550$74.45$2,199,997.50View SEC Filing  
3/3/2015Michael E PrevoznikSVPSell3,261$71.16$232,052.76View SEC Filing  
2/11/2015Daniel StanzioneDirectorSell8,000$70.97$567,760.00View SEC Filing  
2/4/2015Gail R WilenskyDirectorSell8,000$72.34$578,720.00View SEC Filing  
2/3/2015John B ZieglerDirectorSell8,000$71.88$575,040.00View SEC Filing  
2/2/2015Thomas F BongiornoVPSell3,000$71.50$214,500.00View SEC Filing  
11/17/2014Jon R CohenSVPSell160,029$63.13$10,102,630.77View SEC Filing  
8/8/2014Catherine T DohertySVPSell25,000$60.12$1,503,000.00View SEC Filing  
8/4/2014Michael E PrevoznikSVPSell14,377$61.01$877,140.77View SEC Filing  
7/30/2014Jenne K BritellDirectorSell8,000$62.37$498,960.00View SEC Filing  
7/30/2014Michael E PrevoznikSVPSell16,384$62.51$1,024,163.84View SEC Filing  
7/29/2014John C Md BaldwinDirectorSell8,000$62.31$498,480.00View SEC Filing  
7/28/2014Thomas F BongiornoVPSell4,000$61.72$246,880.00View SEC Filing  
7/25/2014John B ZieglerDirectorSell8,000$61.90$495,200.00View SEC Filing  
5/22/2014John ZieglerDirectorSell2,973$57.65$171,393.45View SEC Filing  
5/7/2014Gary PfeifferDirectorSell10,000$55.95$559,500.00View SEC Filing  
5/5/2014Mark GuinanCFOBuy4,000$55.51$222,040.00View SEC Filing  
2/27/2014Jenne BritellDirectorSell10,000$52.74$527,400.00View SEC Filing  
2/19/2014Michael PrevoznikSVPSell2,860$52.26$149,463.60View SEC Filing  
2/18/2014Gail WilenskyDirectorSell30,000$52.93$1,587,900.00View SEC Filing  
2/6/2014Timothy MainDirectorBuy5,000$50.71$253,550.00View SEC Filing  
11/5/2013Thomas F BongiornoVPSell16,667$62.49$1,041,520.83View SEC Filing  
10/29/2013Thomas F BongiornoVPSell6,000$59.00$354,000.00View SEC Filing  
10/25/2013Gary M PfeifferDirectorSell2,000$58.10$116,200.00View SEC Filing  
9/17/2013Catherine DohertySVPSell43,334$62.00$2,686,708.00View SEC Filing  
8/14/2013Catherine DohertySVPSell33,000$59.85$1,975,050.00View SEC Filing  
8/12/2013John ZieglerDirectorSell1,953$59.45$116,105.85View SEC Filing  
8/8/2013Thomas BongiornoVPSell10,864$59.33$644,561.12View SEC Filing  
7/23/2013Jenne K BritellDirectorSell4,200$58.99$247,758.00View SEC Filing  
6/18/2013Michael E PrevoznikSVPSell126,667$62.64$7,934,420.88View SEC Filing  
5/22/2013John B ZieglerDirectorSell31,362$62.00$1,944,444.00View SEC Filing  
5/14/2013John C Md BaldwinDirectorSell1,214$59.41$72,123.74View SEC Filing  
4/11/2013John B ZieglerDirectorSell1,470$58.35$85,774.50View SEC Filing  
1/17/2013Gary M PfeifferDirectorSell10,000$60.00$600,000.00View SEC Filing  
10/3/2012Robert HagemannCFOSell46,667$64.00$2,986,688.00View SEC Filing  
8/7/2012Stephen H RusckowskiCEOBuy5,000$59.34$296,700.00View SEC Filing  
(Data available from 1/1/2013 forward)


Latest Headlines for Quest Diagnostics (NYSE:DGX)
DateHeadline logoQUEST DIAGNOSTICS INC Financials (NYSE:DGX) - October 27 at 3:22 PM
News IconCanaccord Genuity Analysts Give Quest Diagnostics Inc. (DGX) a $90.00 Price Target - DailyQuint (NYSE:DGX) - October 27 at 9:13 AM logoQuest Diagnostics (DGX) Shares Cross 2% Yield Mark - Nasdaq (NYSE:DGX) - October 27 at 9:13 AM logoQuest Diagnostics (DGX) Shares Cross 2% Yield Mark (NYSE:DGX) - October 26 at 4:40 PM
News IconNewsmaking Penny Stock: Investors Checking Out Quest Diagnostics Inc. (NYSE:DGX) - Duncan Research (NYSE:DGX) - October 26 at 7:42 AM logoCommit To Buy Quest Diagnostics At $75, Earn 4.5% Annualized Using Options (NYSE:DGX) - October 25 at 4:37 PM logoQuest Diagnostics, Inc. :DGX-US: Earnings Analysis: Q3, 2016 By the Numbers : October 25, 2016 (NYSE:DGX) - October 25 at 4:37 PM logoQuest Diagnostics, Inc. breached its 50 day moving average in a Bearish Manner : DGX-US : October 24, 2016 (NYSE:DGX) - October 24 at 9:50 AM
News IconQuest Diagnostics Inc. (DGX) Sees Strong Trading Volume After Earnings Beat (NYSE:DGX) - October 22 at 8:50 AM
News IconQuest Diagnostics Inc. (NYSE:DGX) from Medical Laboratories & Research – Todays Top Gains (NYSE:DGX) - October 22 at 8:50 AM
News Icon2 Stocks Analyst-Opinion Need Close Attention: Quest Diagnostics Inc. (NYSE:DGX), The Bank of New York Mellon ... - The Voice Registrar (NYSE:DGX) - October 21 at 4:39 PM logoQUEST DIAGNOSTICS INC Files SEC form 10-Q, Quarterly Report (NYSE:DGX) - October 21 at 4:39 PM
News IconQuest Diagnostics Inc. (DGX) Issues FY16 Earnings Guidance (NYSE:DGX) - October 21 at 7:44 AM
News IconAcadian Asset Management Llc Increased Quest Diagnostics Inc ... - Chester News (NYSE:DGX) - October 20 at 10:01 PM logoEdited Transcript of DGX earnings conference call or presentation 20-Oct-16 12:30pm GMT (NYSE:DGX) - October 20 at 10:01 PM logoQuest Diagnostics (DGX) Tops Q3 Earnings, Narrows View (NYSE:DGX) - October 20 at 4:34 PM logoQuest Diagnostics beats 3Q profit forecasts (NYSE:DGX) - October 20 at 10:03 AM logoQ3 2016 Quest Diagnostics Inc Earnings Release - Before Market Open (NYSE:DGX) - October 20 at 10:03 AM logoQuest Diagnostics (DGX) Tops Q3 Earnings & Revenue Estimates (NYSE:DGX) - October 20 at 10:03 AM logoQuest Diagnostics Inc Earnings Call scheduled for 8:30 am ET today (NYSE:DGX) - October 20 at 10:03 AM logoHealthcare Stocks' Q3 Earnings to Watch on Oct 20: DGX, ICLR - Nasdaq (NYSE:DGX) - October 19 at 4:59 PM logoQuest Diagnostics (DGX) Q3 Earnings: A Surprise in Store? (NYSE:DGX) - October 19 at 9:33 AM logoHealthcare Stocks' Q3 Earnings to Watch on Oct 20: DGX, ICLR (NYSE:DGX) - October 19 at 9:33 AM
News Icon3818 Shares of Quest Diagnostics Inc. (DGX) are sold by Huntington National Bank - DailyQuint (NYSE:DGX) - October 18 at 9:36 AM logoIBM and Quest Diagnostics Launch Watson-Powered Genomic Sequencing Service to Help Physicians Bring Precision Cancer Treatments to Patients Nationwide (NYSE:DGX) - October 18 at 9:36 AM
News IconLeading stocks in today’s market: Quest Diagnostics Inc. (NYSE:DGX) (NYSE:DGX) - October 17 at 9:35 AM
News IconMidas Management Corp decides to keep it stake in Quest Diagnostics Inc. (DGX) to the level of $2279000 - DailyQuint (NYSE:DGX) - October 15 at 4:27 PM logo'Mad Money' Lightning Round: AMD Is Coming Back (NYSE:DGX) - October 15 at 9:27 AM
News IconQuest Diagnostics Inc. (NYSE: DGX) – Is this large market cap stock undervalued? - The Daily Leicester (NYSE:DGX) - October 14 at 4:31 PM logoQuest Diagnostics: Product Launches, Alliances to Add Value (NYSE:DGX) - October 14 at 4:31 PM logoMission for Mazuma's first CIO: build a comprehensive digital strategy (NYSE:DGX) - October 13 at 4:34 PM logoMedical Laboratories & Research Stocks Technical Reports -- Quest Diagnostics, Alere, Organovo, and DexCom - PR Newswire (press release) (NYSE:DGX) - October 12 at 9:55 PM
News IconPattern of the Day: Is Major Move Coming For Quest Diagnostics Inc After This Bullish Multiple Top Chart Pattern? - Chester News (NYSE:DGX) - October 12 at 9:55 PM logoQuest Diagnostics, Inc. breached its 50 day moving average in a Bearish Manner : DGX-US : October 12, 2016 (NYSE:DGX) - October 12 at 9:26 AM
News IconMedical Laboratories & Research: Quest Diagnostics Inc. (NYSE:DGX) Position of the day (NYSE:DGX) - October 10 at 4:27 PM logoThese 5 Rocket Stocks Are Ready for Blastoff This Fall (NYSE:DGX) - October 10 at 4:27 PM
News IconTop Earnings to Watch for: Quest Diagnostics Inc. (NYSE:DGX) - The Voice Registrar (NYSE:DGX) - October 8 at 4:27 PM
News IconA look at a High Market Cap Stock: Quest Diagnostics Inc., DGX ... - The Daily Leicester (NYSE:DGX) - October 7 at 4:33 PM
News IconPattern to Watch: Quest Diagnostics Inc Formed a Double Top Chart Pattern, Could Be One of The Best Performers Soon - Chester News (NYSE:DGX) - October 7 at 9:33 AM logoQuest Diagnostics To Release Third Quarter 2016 Financial Results On October 20 (NYSE:DGX) - October 6 at 4:33 PM
News IconHow has Quest Diagnostics Inc.:(NYSE:DGX) performed recently? - The Daily Leicester (NYSE:DGX) - October 6 at 10:11 AM logoTheranos Becomes A Shadow Of Its Imagined Self (NYSE:DGX) - October 6 at 10:11 AM
News IconTop Gainers of the Day: Quest Diagnostics Inc. (NYSE:DGX) from Medical Laboratories & Research (NYSE:DGX) - October 5 at 9:48 AM
News IconIs Quest Diagnostics Inc. (NYSE:DGX), a large market cap stock a smart buy? (NYSE:DGX) - October 4 at 9:29 AM logoQuest Diagnostics, Inc. – Value Analysis (NYSE:DGX) : October 3, 2016 (NYSE:DGX) - October 3 at 4:27 PM logoQuest Diagnostics, Inc. breached its 50 day moving average in a Bearish Manner : DGX-US : September 30, 2016 (NYSE:DGX) - September 30 at 9:41 AM
News IconBroker Roundup For Quest Diagnostics Incorporated (NYSE:DGX) (NYSE:DGX) - September 29 at 9:37 AM logoEx-Dividend Reminder: Sanderson Farms, Quest Diagnostics and Agilent Technologies (NYSE:DGX) - September 28 at 4:30 PM logoAT&T Becomes #202 Most Shorted S&P 500 Component, Replacing Quest Diagnostics (NYSE:DGX) - September 27 at 4:35 PM logoQuest Diagnostics To Host Investor Day On November 11, 2016 (NYSE:DGX) - September 27 at 4:35 PM


Quest Diagnostics (NYSE:DGX) Chart for Thursday, October, 27, 2016

Last Updated on 10/27/2016 by Staff